Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studiesBNT162b2 및 mRNA-1273 백신 유도 중화항체의 중증급성호흡기증후군-CoV-2 변이체에 대한 효능: 시험관 내 연구의 체계적인 검토Review Published on 2022-03-012022-09-11 Journal: Reviews in Medical Virology [Category] MERS, SARS, 변종, 진단, [키워드] (Alpha) (Beta) acute respiratory syndrome addition Alpha antibodies antibody B.1.1.7 B.1.1.7 variant B.1.351 B.1.351 variant B.1.617.2 Beta bioRxiv BNT162b2 CONSORT Delta dose Effectiveness elicited eligibility criteria Emergency use authorization Gamma immune immunized in vitro study individual Live virus medRxiv mRNA mRNA vaccine mRNA vaccines mRNA-1273 mRNA-based vaccine neutralization Neutralization assay neutralized Neutralizing Neutralizing antibodies neutralizing antibody of BNT162b2 P.1 platform potency pseudovirus raised reduced Reporting respiratory SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants searched sensitivity sera Standard systematic review titre vaccinated individual vaccinated individuals vaccination variant variants variants of concern viruses was used Web of Science [DOI] 10.1002/rmv.2277 PMC 바로가기 [Article Type] Review
A tabulated summary of the evidence on humoral and cellular responses to the SARS-CoV-2 Omicron VOC, as well as vaccine efficacy against this variantSARS-CoV-2 Omicron VOC에 대한 체액 및 세포 반응에 대한 증거와 이 변이체에 대한 백신 효능에 대한 표 요약Review Published on 2022-03-012022-09-11 Journal: Immunology letters [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 appear appearance article B.1.1.529 bioRxiv Booster vaccine carried Cellular immune response cellular response coronavirus COVID-19 databases distribution dose Effectiveness Efficacy Evidence forms health authorities Health authority humoral humoral immune response Humoral response Immune escape immune system individual ineffectiveness infections medRxiv Mutation Neutralizing antibodies omicron preserved provided responsible SARS-CoV-2 severe acute respiratory syndrome Coronavirus solution South Africa SRAS-CoV-2 symptomatic the SARS-CoV-2 These data Transmission vaccination Vaccine Vaccine against COVID-19. variant variants virus VoC [DOI] 10.1016/j.imlet.2022.02.002 PMC 바로가기 [Article Type] Review
Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine코로나19 백신을 이용한 이종 프라임-부스트 면역의 반응원성과 면역원성Review Published on 2022-03-012022-09-11 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 변종, 임상, [키워드] adverse events bioRxiv Cellular immune response Characteristics clinical trial clinical trials Cochrane Library COVID-19 COVID-19 vaccination database delta variant evaluated Evidence Final Heterologous heterologous prime-boost heterologous prime-boost immunization heterologous vaccination regimen heterologous vaccination regimens humoral immune response immunogenic immunogenicity Inactivated vaccine instrument medRxiv mRNA mRNA-based vaccine New observational studies outcome pandemic Prime-boost provided reactogenicity regimen risk Risk of bias robust searched selected Support systemic reactions Systemic review tolerable vaccination Vaccine vaccine administration variant with COVID-19 [DOI] 10.1016/j.biopha.2022.112650 PMC 바로가기 [Article Type] Review
Modelling of Waning of Immunity and Reinfection Induced Antibody Boosting of SARS-CoV-2 in Manaus, Brazil브라질 마나우스에서 SARS-CoV-2의 면역 약화 및 재감염 유도 항체 부스팅 모델링Article Published on 2022-02-022022-09-10 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] age attack rates Blood blood donor Blood donors boosting of immunity Brazil can be used city COVID-19 death Donor exceeded explain First wave Gamma herd immunity Herd immunity threshold Hospitalization Immunity induced Infection magnitude medRxiv P.1 Reinfection repeated reported SARS-CoV-2 second wave serological data Transmissibility variant of SARS-CoV-2 waning of immunity were infected [DOI] 10.3390/ijerph19031729 PMC 바로가기 [Article Type] Article
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative reviewSARS-CoV-2 및 우려 변종에 대한 특성, 효능 및 효과에 대한 COVID-19 백신 비교: 서술적 검토Review Published on 2022-02-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adverse effects adverse event adverse events agency Alpha Analysis anaphylaxis AZD1222 benefit Beta bioRxiv BNT162b2 booster dose Characteristics Comparative analysis CoronaVac coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Critical death Delta Delta variants dose doses effective Effectiveness Efficacy Evidence Gamma Google Scholar Heterologous highest Hospitalization Immunity immunization Infection mass vaccination medRxiv mRNA mRNA vaccine mRNA vaccines mRNA-1273 myocarditis pandemic Phase III trials Prevent reduced reference Regulatory review Safe SARS-CoV-2 SARS-COV-2 infection seroneutralization severe acute respiratory syndrome Coronavirus severe COVID-19 Severe infection severe infections symptomatic symptomatic case symptomatic cases symptomatic COVID-19 the vaccine vaccination Vaccine Vaccines variant variants variants of concern waning immunity website [DOI] 10.1016/j.cmi.2021.10.005 PMC 바로가기 [Article Type] Review
Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic reviewResearch article Published on 2022-02-012022-10-05 Journal: Clinical neurology and neurosurgery [Category] 진단, 치료법, [키워드] age aggregate article Autoimmune disorders Azithromycin Characteristics Clinical course Clinical outcome clinical study collected data Comorbidities confirmed COVID-19 case coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis COVID-19 patients COVID-19 treatments database diabete Diagnosis diagnostic testing Evidence exaggerate female Follow-up hospital Intravenous immunoglobulin invasive ventilation medRxiv Mortality mortality rate Myasthenia myasthenia gravis Neurological symptom Neuromuscular disorders numbers of patient objective outcome Patient patients percentage performed Prednisone presenting provide recent reported required Result RT-PCR tests searched Support Symptoms systematic review Treatment Ventilation was used Web of Science Weighting [DOI] 10.1016/j.clineuro.2022.107140 [Article Type] Research article
An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19몰누피라비르 사용에 대한 업데이트된 실제 지침 및 COVID-19 치료를 위한 긴급 사용 승인을 받은 약제와의 비교Clinical Trial Published on 2022-02-012022-09-11 Journal: Diabetes & metabolic syndrome [Category] COVID19(2023년), SARS, 변종, 비임상, 신약개발, 임상, 치료법, 치료제, [키워드] 95% CI antiviral drug appear Bamlanivimab–etesevimab breath Casirivimab–imdevimab confidence interval Course COVID-19 COVID-19 patient database death effective Emergency use authorization EUA Google Scholar Hospital admission Hospitalization increased risk India medRxiv molnupiravir Nirmatrelvir Nirmatrelvir-ritonavir number onset of symptoms P-value patients with COVID-19 people with COVID-19 phase 3 study Prevent reduction in Relative risk Remdesivir reported risk risk difference risk reduction Ritonavir Safe SARS-CoV-2 searched severity Side effects Sotrovimab systematic review treat Treatment USA with COVID-19 [DOI] 10.1016/j.dsx.2022.102396 PMC 바로가기 [Article Type] Clinical Trial
Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysisCOVID-19 환자의 토 실리 주맙 치료와 임상 결과 사이의 연관성 : 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-01-312022-09-01 Journal: Aging (Albany NY) [Category] 임상, 진단, [키워드] adverse events Affect all-cause mortality Analysis association benefit carried Clinical outcome clinical outcomes control group COVID-19 COVID-19 patients death decrease discharge Efficacy heterogeneity hospital discharge infection risk intubation medRxiv Meta-analysis nine Patient patients with COVID-19 peer-reviewed performed Randomized controlled trial RCT RCTs reduced reductions reductions in risk searched Secondary infection secondary infections Serious Adverse Events significantly significantly increased Still systematic review Tocilizumab treat Treatment treatment with tocilizumab [DOI] 10.18632/aging.203834 PMC 바로가기 [Article Type] Meta-Analysis
Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports중증 급성 호흡기 증후군 코로나바이러스 2 감염의 체액 면역 역학 및 코로나바이러스 질병 2019에 대한 혈청학적 분석의 진단 성능: 글로벌 보고서 분석Review Published on 2022-01-192022-09-11 Journal: International health [Category] SARS, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgM applicability article Blood Characteristics chemiluminescence immunoassay CLIA coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 serology diagnosis of COVID-19 diagnostic diagnostics eligible ELISA epidemiological purposes followed by humoral immune response IgG IgM immunological IMPROVE in some Infection Kinetics Laboratory laboratory diagnosis Laboratory tests lateral flow medical subject heading Medical Subject Headings medRxiv MONITOR pandemic peaked performance POCT point-of-care Postinfection protocol provide reported Research SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 test searched second wave serological Serological assay serological assays serological test serology severe acute respiratory syndrome Coronavirus thresholds total antibodies total antibody was performed Web of Science [DOI] 10.1093/inthealth/ihab005 PMC 바로가기 [Article Type] Review
Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials코로나19 환자에서 아지스로마이신의 효능 및 안전성: 무작위 임상시험에 대한 체계적 고찰 및 메타분석Review Published on 2022-01-012022-09-11 Journal: Reviews in Medical Virology [Category] SARS, 임상, [키워드] 95% CI adverse event adverse events Analysis antimicrobial resistance Azithromycin Bacterial bioRxiv clinical clinical benefit Cochrane Library controlled trials COVID-19 COVID-19 patients death Efficacy estimate Evidence FIVE Google Scholar heterogeneity Invasive mechanical ventilation investigated lack males median median age medians medRxiv Meta-analysis Mortality Odds ratio outcomes Patient patients randomized potential risk random-effects model randomized clinical trial Randomized controlled trials risk risk of bia Safety searched Seven Standard of care systematic review therapy Trial was used were used [DOI] 10.1002/rmv.2258 PMC 바로가기 [Article Type] Review